Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Journal of Clinical Medicine|June 28, 2023
Editorial on: Musculoskeletal Rehabilitation: Current Challenges and New PerspectivesAndrea Perna, Luca ProiettiMechanisms of Ageing and Development|March 17, 2021
The emerging role of Cockayne group A and B proteins in ubiquitin/proteasome-directed protein degradationElena Paccosi, Luca Proietti-De-SantisRivista Di Psichiatria|July 25, 2012
[Pharmacotherapy plus psychotherapy in patients with mood disorder and Axis II codiagnosis. A review]Antonio Tundo, Luca Proietti, Paola CavalieriCell Cycle (Georgetown, Tex.)|February 18, 2009
Cockayne syndrome B protein (CSB): linking p53, HIF-1 and p300 to robustness, lifespan, cancer and cell fate decisionsMattia Frontini, Luca Proietti-De-SantisAging|March 3, 2012
Interaction between the Cockayne syndrome B and p53 proteins: implications for agingMattia Frontini, Luca Proietti-De-SantisInternational Journal of Molecular Sciences|June 10, 2023
Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based StrategyElena Paccosi, Luca Proietti-De-SantisWorld Journal of Psychiatry|October 2, 2015
Pharmacologic approaches to treatment resistant depression: Evidences and personal experienceAntonio Tundo, Rocco de Filippis, Luca ProiettiBioorganic & Medicinal Chemistry|December 24, 2013
Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-onesCinzia Conti, Luca Proietti Monaco, Nicoletta DesideriBioorganic & Medicinal Chemistry|March 1, 2017
3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitorsCinzia Conti, Luca Proietti Monaco, Nicoletta DesideriBioorganic & Medicinal Chemistry|November 18, 2011
Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitorsCinzia Conti, Luca Proietti Monaco, Nicoletta DesideriPageof 12